Search

MR is a progressive disease, and patients may remain asymptomatic even when the condition has become severe, as compensatory mechanisms develop.11 In some cases, the following symptoms may be experi

Two Types of Mitral Regurgitation 1-YEAR MORTALITY UP TO 57%* Mitral regurgitation, if left untreated, initiates a ca

Large effective orifice areas.1,2 Single-digit gradients.1,2 30-day Echo Core Lab Data1,2 HEMODYNAMIC IMPACT Non-tapered stent and large effective orifice areas resulting in single-digit gradie

MitraClip™ + GDMT patients were more likely to be in NYHA functional class I or II throughout the 5 years MitraClip™ + GDMT patients benefited from a 47% relative risk reduction in HFH/ Death versu

SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding LAA Occlusion HOW DOES IT WORK? SUPPORTED BY GUIDELINES, PROVEN BY DATA PROVEN R

The objective of this trial is to evaluate the safety and effectiveness of the Amulet™ LAA Occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke an

Summary of current relevant international guidelines on the diagnosis of TR TR should be evaluated first by echocardiography. In primary TR, specific abnormalities of the valve can be identified.

CONFIDENTLY IMPLANT THE MOST TRUSTED AORTIC MECHANICAL VALVES IN THE WORLD

MASTERS™ SERIES IMPLANTABILITY OPTIONS WITH MASTERS™ SERIES The Masters™ series mechanical heart valves are rotatable, bileaflet valves designed for secure implantation. The portfolio includes an e

REGENT™ REGENT™ GIVES YOU IMPLANTABILITY OPTIONS TWO DISTINCT CUFF TYPES PROVIDE YOU WITH DIFFERENT OPTIONS *Measured one-year post-surgery.